Exhaled nitric oxide and tracheal endothelin-1 in preterm infants with and without RDS†
Steven L. Olsen MD
Section of Neonatology, Department of Pediatrics, Children's Mercy Hospitals and Clinics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri
Search for more papers by this authorPerry L. Clark MD
Department of Pediatrics, University of Kansas School of Medicine, Kansas City, Kansas
Search for more papers by this authorDonald W. Thibeault MD
Section of Neonatology, Department of Pediatrics, Children's Mercy Hospitals and Clinics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri
Search for more papers by this authorMike Norberg
Section of Neonatology, Department of Pediatrics, Children's Mercy Hospitals and Clinics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri
Search for more papers by this authorCorresponding Author
William E. Truog MD
Section of Neonatology, Department of Pediatrics, Children's Mercy Hospitals and Clinics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri
Section of Neonatology, Children's Mercy Hospitals and Clinics, 2401 Gillham Road, Kansas City, MO 64108.Search for more papers by this authorSteven L. Olsen MD
Section of Neonatology, Department of Pediatrics, Children's Mercy Hospitals and Clinics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri
Search for more papers by this authorPerry L. Clark MD
Department of Pediatrics, University of Kansas School of Medicine, Kansas City, Kansas
Search for more papers by this authorDonald W. Thibeault MD
Section of Neonatology, Department of Pediatrics, Children's Mercy Hospitals and Clinics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri
Search for more papers by this authorMike Norberg
Section of Neonatology, Department of Pediatrics, Children's Mercy Hospitals and Clinics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri
Search for more papers by this authorCorresponding Author
William E. Truog MD
Section of Neonatology, Department of Pediatrics, Children's Mercy Hospitals and Clinics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri
Section of Neonatology, Children's Mercy Hospitals and Clinics, 2401 Gillham Road, Kansas City, MO 64108.Search for more papers by this authorThis work was presented in part at the annual meeting of the Pediatric Academic Societies, Baltimore, MD, 2001.
Abstract
We measured exhaled nitric oxide and tracheal aspirate endothelin-1 to determine relationships between these substances and alterations in pulmonary gas exchange during respiratory distress syndrome (RDS) in comparison to those obtained from control preterm infants without RDS. Eight infants with RDS had measurements made at 24 hr and again at 48–72 hr. Eight control infants were studied once at 24–48 hr of life. Exhaled gas was analyzed on-line, and minute excretion of NO (V̇NO) was calculated. ET-1 was determined by immunoassay. Median V̇NO at 24 hr in RDS was 0.405 nl/min/kg (range, 0.30 –0.79), which subsequently declined by 48–72 hr to 0.166 nl/min/kg (P < 0.01). The V̇NO in RDS infants was significantly higher than time-matched V̇NO in controls, with a median of 0.099 nl/min/kg (range, 0.03–0.27; P < 0.001). ET-1 was not correlated with initial V̇NO in the RDS or control patients. In conclusion, in RDS, V̇NO decreases as gas exchange improves. ET-1 is detectable in tracheal aspirate samples in both groups of infants. Pediatr Pulmonol. 2003; 36:421–426. © 2003 Wiley-Liss, Inc.
REFERENCES
- 1 Gill AB, Weindling AM. Pulmonary artery pressure changes in the very low birth weight infant developing chronic lung disease. Arch Dis Child 1993; 68: 303–307.
- 2 Subhedar NV, Hamdan AH, Ryan SW, Shaw NJ. Pulmonary artery pressure: early predictor of chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 1998; 78: 20–24.
- 3 Endo A, Ayusawa M, Minato M, Takada M, Takahashi S, Harada K. Physiologic significance of nitric oxide and endothelin-1 in circulatory adaptation. Pediatr Int 2000; 42: 26–30.
- 4 Hutte RS. Techniques for the measurement of nitric oxide and its reaction products. In: S Moncada, J Stamler, S Gross, EA Higgs, editors. The biology of nitric oxide, part 5. London: Portland Press; 1996. p 172–174.
- 5 Pallotto E, Banks BA, Truog W, Cnaan A, Cohen B, Merrill JD, Ballard RA. Endothelin (ET-1) and nitric oxide metabolite levels with persistent pulmonary hypertension (PPHN) treated with inhaled nitric oxide (INO) therapy. Pediatr Res 2001; 49: 268.
- 6 Goil S, Truog WE, Barnes C, Norberg M, Rezaiekhaligh M, Thibeault D. Eight-epi-PGF2α: a possible marker of lipid peroxidation in term infants with severe pulmonary disease. J Pediatr 1998; 132: 349–351.
- 7 Goil S, Barnes C, Thibeault D, Truog WE. Simplified method for purification of colostrum to obtain secretory component of immunoglobulin A, using secretory component as a reference protein in tracheal aspirate fluid. J Chromatogr [B] 1998; 705: 203–211.
- 8 Dweik RA, Laskowski D, Abu-Sound HM, Kaneko F, Hutte R, Stuehr DJ, Erzarum SC. Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J Clin Invest 1998; 101: 660–666.
- 9 Pitt BR, St. Croix CM. Complex regulation of iNOS in lung. Am J Respir Cell Mol Biol 2002; 26: 6–9.
- 10 Truog WE, Norberg M, Thibeault DW. Effect of inhaled nitric oxide in endothelin-1-induced pulmonary hypertension. Biol Neonate 1998; 73: 246–253.
- 11 Black SM, Johengen MJ, Soifer SJ. Coordinated regulation of genes of the nitric oxide and endothelin pathways during the development of pulmonary hypertension in fetal lambs. Pediatr Res 1998; 44: 821–830.
- 12 Kobayashi H, Puri P. Plasma endothelin levels in congenital diaphragmatic hernia. J Pediatr Surg 1994; 29: 1258–1261.
- 13 Dobyns EL, Eells PL, Griebel JL, Abman SH. Elevated plasma endotehlin-1 and cytokine levels in children with severe acute respiratory distress syndrome. J Pediatr 1999; 135: 246–249.
- 14 Niu Jo, Munski UK, Siddig MM, Parton LA. Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia. J Pediatr 1998; 132: 965–970.
- 15 Groneck P, Schmale J, Soditt V, Stutzer H, Gotze-Speer B, Speer CP. Bronchoalveolar inflammation following airway infections in preterm infants with chronic lung disease. Pediatr Pulmonol 2001; 31: 331–338.
- 16 Wort SJ, Woods M, Warner TD, Evans TW, Mitchell JA. Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation. Relevance to pathogenesis of pulmonary hypertension and vascular remodeling. Am J Respir Cell Mol Biol 2001; 25: 104–110.
- 17 Perreault T, Berkenbosch JW, Barrington KJ, Decker ER, Wu C, Brock TA, Baribeau J. TBC3711, and ETA receptor antagonist, reduce neonatal hypoxia-induced pulmonary hypertension in piglets. Pediatr Res 2001; 50: 374–383.
- 18 Jankov RP, Luo X, Belcastro R, Copland I, Frndova H, Lye SJ, Hoidal JR, Post M, Tanswell AK. Gadolinium chloride inhibits pulmonary macrophage influx and prevents O2-induced pulmonary hypertension in the neonatal rat. Pediatr Res 2001; 50: 172–183.
- 19 Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children—1999. Am J Respir Crit Care Med 1999; 160: 2104–2116.
- 20 Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1693–1722.
- 21 Adrie C, Monchi M, Dinh-Xuan AT, Dall'Ava-Santucci J, Dhainaut JF, Pinsky MR. Exhaled and nasal nitric oxide as a marker of pneumonia in ventilated patients. Am J Respir Crit Care Med 2001; 163: 1143–1149.
- 22 Schedin U, Norman M, Gustafsson LE, Herin P, Frostell C. Endogenous nitric oxide in the upper airways of healthy newborn infants. Pediatr Res 1996; 40: 148–151.
- 23 Schedin U, Norman M, Gustafsson LE, Jonsson B, Frostell C. Endogenous nitric oxide in the upper airways of premature and term infants. Acta Paediatr Scand 1997; 86: 1229–1235.
- 24 Artlich A, Busch T, Lewandowski K. Schaible T, Falke K, Gortner L. Exhaled nitric oxide in preterm infants. Respir Physiol 1998; 114: 195–200.
- 25 Biban P, Zangardi T, Baraldi E, Dussini N, Chiandetti L, Zacchello F. Mixed exhaled nitric oxide and plasma nitrites and nitrates in newborn infants. Life Sci 2001; 68: 2789–2797.
- 26 Aikio O, Pokela ML, Hallman M. Exhaled and nasal nitric oxide in mechanically ventilated preterm and term newborns. Acta Paediatr Scand 2002; 92: 1078–1086.
- 27 Grasemann H, Knauer N, Buscher R, Hubner K, Drazen JM, Ratjen F. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am J Respir Crit Care Med 2000; 162: 2172–2176.
- 28 Wechsler ME, Grasemann H, Deykin A, Silverman EK, Yandava CN, Israel E, Wand M, Drazen JM. Exhaled nitric oxide in patients with asthma: association with NOS1 genotype. Am J Respir Crit Care Med 2000; 162: 2043–2047.